Juergen Hammer

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning

Francesco Sinigaglia, Juergen Hammer, Elisa Bono, 1994, The Journal of experimental medicine.

Identification of a motif for HLA-DR1 binding peptides using M13 display libraries

F. Sinigaglia, B. Takács, J. Hammer, 1992, The Journal of experimental medicine.

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

R. Karr, J. Guenot, Z. Nagy, 1995, The Journal of experimental medicine.

Melanoma Cells Present a Mage-3 Epitope to Cd4 Ϩ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen Dr11

P. Dellabona, C. Noppen, T. Sturniolo, 1999 .

The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library.

L Adorini, L C Harrison, L. Adorini, 2000, International immunology.

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis

F. Falcioni, Z. Nagy, D. Bolin, 1996, The Journal of experimental medicine.

Motifs and supermotifs for MHC class II binding peptides

F. Sinigaglia, J. Hammer, F Sinigaglia, 1995, The Journal of experimental medicine.

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning

Z. Nagy, F. Sinigaglia, E. Bono, 1994, The Journal of experimental medicine.